跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
3-15
首页
药物
3-15
3-15
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Process for preparing (15 [alpha], 16 [alpha], 17 [beta])-estra-1, 3, 5 (10)-triene-3, 15, 16, 17-tetraol (estetrol) monohydrate
申请人: IND CHIMICA SRL
优先权: 2021
CN
Process for preparing (15 [alpha], 16 [alpha], 17 [beta])-estra-1, 3, 5 (10)-triene-3, 15, 16, 17-tetraol monohydrate (estetrol monohydrate)
申请人: IND CHIMICA SRL
优先权: 2019
CN
2 件公开
15 beta-[3-propionamido]-substituted estra-1, 3, 5 (10)-triene-17-ones and 17-oximes
申请人: FORENDO PHARMA LTD
优先权: 2017
CN
3-heteroatom substituted and two carbon homologs of 15-HETE and methods of use
申请人: ALCON UNIVERSAL LTD
优先权: 2000
US
3 件公开
Compound of 3, 15-dicarbonyl erythro mildew acid kind and its ester and salt
申请人: UNIV YUNNAN
优先权: 2004
CN
LAG-3 TARGETED HETERODIMERIC FUSION PROTEINS CONTAINING IL-15/IL-15RA FC-FUSION PROTEINS AND LAG-3 ANTIGEN BINDING DOMAINS
申请人: XENCOR INC
优先权: 2018
CN
EP
US
WO
7 件公开
TIM-3 targeted heterodimeric fusion proteins containing IL-15/IL-15RA Fc-fusion proteins and TIM-3 antigen binding domains
申请人: XENCOR INC
优先权: 2018
CN
US
2 件公开
3-O-aralkyl substituted 15-membered aza-lactone derivative and preparation method and application thereof
申请人: HENAN PROVINCIAL PEOPLES HOSPITAL
优先权: 2021
CN
药物
反馈